Literature DB >> 2664516

The cardiovascular response of normal humans to the administration of endotoxin.

A F Suffredini1, R E Fromm, M M Parker, M Brenner, J A Kovacs, R A Wesley, J E Parrillo.   

Abstract

Marked abnormalities in cardiovascular function accompany septic shock, and bacterial endotoxin is believed to be one of the principal mediators of these abnormalities. To evaluate the cardiovascular effects of endotoxemia in humans, we measured hemodynamic variables in nine normal subjects given an intravenous bolus dose of endotoxin (Escherichia coli, 4 ng per kilogram of body weight) and in six normal subjects given a bolus dose of saline, before and three hours after administration. All the subjects then underwent volume loading with normal saline (mean, 2217 ml) during the fourth and fifth hours after administration of the bolus, and the measurements were repeated. Three hours after the administration of endotoxin and before volume loading, the cardiac index had increased by 53 percent and the heart rate by 36 percent (both changes were significant; P less than or equal to 0.008), and the systemic vascular-resistance index had decreased by 46 percent (P = 0.004). After volume loading (five hours after the administration of endotoxin), the left ventricular ejection fraction decreased by 1 percent of the base-line value in the subjects given endotoxin, but increased by 14 percent in the controls (P = 0.008). The left ventricular end-diastolic and end-systolic volume indexes increased by 18 percent (P = 0.07) and 24 percent (P = 0.042), respectively. Left ventricular performance, as measured by the ratio of the peak systolic pressure to the end-systolic volume index, was depressed (a decrease of 0.90 in the subjects given endotoxin vs. an increase of 0.76 in the controls; P = 0.024). We conclude that the administration of endotoxin to normal subjects causes a depression of left ventricular function that is independent of changes in left ventricular volume or vascular resistance. The changes in function are similar to those observed in septic shock and suggest that endotoxin is a major mediator of the cardiovascular dysfunction in this condition.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2664516     DOI: 10.1056/NEJM198908033210503

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  190 in total

Review 1.  Clinical implications of tumour necrosis factor alpha antagonism in patients with congestive heart failure.

Authors:  G Torre-Amione; S S Stetson; J A Farmer
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  New insights into the biology of the acute phase response.

Authors:  A F Suffredini; G Fantuzzi; R Badolato; J J Oppenheim; N P O'Grady
Journal:  J Clin Immunol       Date:  1999-07       Impact factor: 8.317

Review 3.  Activation of cytokines as a mechanism of disease progression in heart failure.

Authors:  B Bozkurt
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 4.  Statins and the role of nitric oxide in chronic heart failure.

Authors:  Stephan von Haehling; Stefan D Anker; Eberhard Bassenge
Journal:  Heart Fail Rev       Date:  2003-01       Impact factor: 4.214

Review 5.  [Endotoxins. Pathogenetic meaning of sepsis].

Authors:  H Rensing
Journal:  Anaesthesist       Date:  2003-12       Impact factor: 1.041

6.  Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium.

Authors:  R Schulz; E Nava; S Moncada
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

Review 7.  The evolving experience with therapeutic TNF inhibition in sepsis: considering the potential influence of risk of death.

Authors:  Ping Qiu; Xizhong Cui; Amisha Barochia; Yan Li; Charles Natanson; Peter Q Eichacker
Journal:  Expert Opin Investig Drugs       Date:  2011-10-01       Impact factor: 6.206

Review 8.  Muscle KATP channels: recent insights to energy sensing and myoprotection.

Authors:  Thomas P Flagg; Decha Enkvetchakul; Joseph C Koster; Colin G Nichols
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

9.  New-Onset Heart Failure and Mortality in Hospital Survivors of Sepsis-Related Left Ventricular Dysfunction.

Authors:  Saraschandra Vallabhajosyula; Jacob C Jentzer; Jeffrey B Geske; Mukesh Kumar; Ankit Sakhuja; Akhil Singhal; Joseph T Poterucha; Kianoush Kashani; Joseph G Murphy; Ognjen Gajic; Rahul Kashyap
Journal:  Shock       Date:  2018-02       Impact factor: 3.454

10.  The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure.

Authors:  S J De Kimpe; M Kengatharan; C Thiemermann; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.